SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production.
Chen L, Shi V, Wang S, Sun L, Freeman R, Yang J, Inkman MJ, Ghosh S, Ruiz F, Jayachandran K, Huang Y, Luo J, Zhang J, Cosper P, Luke CJ, Spina CS, Grigsby PW, Schwarz JK, Markovina S.
Chen L, et al. Among authors: jayachandran k.
J Clin Invest. 2023 Aug 1;133(15):e163841. doi: 10.1172/JCI163841.
J Clin Invest. 2023.
PMID: 37279067
Free PMC article.